small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (489)
  • Capabilities (82)
  • Experience (193)
  • Insights & News (5,226)
  • Other Results (127)

Professionals 489 results

T. Reed Stephens
T. Reed Stephens
Partner
  • Washington, DC
Email
+1 202-282-5795
vCard

Partner

  • Washington, DC
Charlie Papavizas
Charlie Papavizas
Partner
  • Washington, DC
Email
+1 202-282-5732
vCard

Partner

  • Washington, DC
Cari Stinebower
Cari Stinebower
Partner
  • Washington, DC
Email
+1 202-282-5788
vCard

Partner

  • Washington, DC
View All Professionals

Capabilities 82 results

Industry

Medical Devices

The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative healthcare landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Healthcare & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions....Read more

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Practice Area

Government Program Fraud, False Claims Act & Qui Tam Litigation

Investigations and litigation involving alleged fraud against the government pose a significant and growing threat to organizations and individuals across all industries that engage directly or indirectly in business with federal, state, and/or local governments. The government makes aggressive use of its extensive criminal and civil investigatory powers to root out alleged fraud and abuse implicating government funds, including one of its most powerful civil enforcement tools—the federal False Claims Act (FCA)—and similar state false claims statutes....Read more

Experience 193 results

Experience

|

September 22, 2025

Winston Paris advised the founders and shareholders of Bylaw, on its acquisition by Septeo

Founded in 2019 by Adrien Aboudaram and Tuan Ardouin, Bylaw has developed next-generation AI technology to automate the processing of legal and financial documents. With a team primarily dedicated to R&D, the legaltech company aims to become the leading AI reference for regulated professions....Read more

Experience

|

September 10, 2025

$1.05 Billion PECO Energy Company Public Offering of First and Refunding Mortgage Bonds

We served as underwriters' counsel to BNY Capital Markets, Citigroup, PNC Capital Markets LLC, Scotiabank, US Bancorp, Mizuho and MUFG, as joint book-running managers, in connection with the registered public offering of $1.05 billion of First and Refunding Mortgage Bonds by PECO Energy Company comprised of $525 million 4.875% First and Refunding Mortgage Bonds due 2035 and $525 million 5.650% First and Refunding Mortgage Bonds due 2055....Read more

Experience

|

September 9, 2025

Greenland Exploration Limited enters business combination with Pelican Acquisition Corporation and March GL Company

Winston & Strawn LLP represented Greenland Exploration Limited in a landmark business combination with Pelican Acquisition Corporation (NASDAQ: PELI) and March GL Company. The transaction, structured as a merger agreement, will result in the formation of Greenland Energy Company, expected to be publicly listed on NASDAQ under the ticker symbol “GLND.” Winston advised Greenland Exploration on all aspects of the deal, including regulatory strategy, corporate structuring, and negotiation of the merger terms....Read more
View All Experience

Insights & News 5,226 results

Seminar/CLE

|

November 13, 2025

AI in Action: Legal Strategies for Responsible Innovation and Investments

Houston, we have innovation. With 78% of organizations now using AI in at least one business function, the race is on to navigate sector-specific adoption with precision. In Space City—where manufacturing, aerospace, aviation, energy, and healthcare fuel the economy—legal and business leaders must prepare for liftoff....Read more

Client Alert

|

November 10, 2025

|

6 Min Read

U.S. Treasury Seeks Public Comment on the Implementation of the GENIUS Act

On September 19, 2025, the U.S. Department of the Treasury (Treasury) issued an Advance Notice of Proposed Rulemaking (ANPRM) to solicit public comment on questions relating to the implementation of the Guiding and Establishing National Innovation for U.S. Stablecoins (GENIUS) Act. Through this ANPRM, Treasury sought feedback on a wide range of potential regulatory issues, including clarity around issuance and marketing restrictions, compliance with the Bank Secrecy Act (BSA) obligations, anti-money laundering (AML) and sanctions enforcement, coordination between state and federal oversight, foreign regulatory comparability, and tax implications.

Capital Markets & Securities Law Watch

|

November 10, 2025

|

4 Min Read

ExxonMobil's Game-Changer: SEC Approves Standing Voting Instructions (SVIs) for Retail Investors

ExxonMobil Corporation (Exxon) recently made headlines as the first U.S. public company to receive a green light from the SEC for a retail voting program based on Standing Voting Instructions (SVIs), officially known as the Exxon Voter Pool.

View All Insights & News

Other Results 127 results

Site Content

The Corporate Transparency Act
Task Force

Site Content

What Is The Jones Act?

The Jones Act, as used in the world of shipping is a law that reserves the transportation of goods between two points in the United States to qualified U.S.-flag vessels. This coastwise reservation law is named after its chief sponsor, Senator Wesley L. Jones. Similar laws apply to the transportation of passengers and reserve towing, dredging, and fishing in U.S. waters to qualified U.S.-flag vessels. Such vessels must be U.S. citizen-owned, U.S. citizen-crewed, U.S.-registered, and U.S.-built. Another law, also called the “Jones Act,” relates to merchant mariner injury recoveries....Read more

Site Content

What Is the Securities Act of 1933?

The Securities Act of 1933 (as amended, the “Securities Act”) was passed to ensure that investors have financial and other important information about securities that are being sold publicly. It also bans the use of fraud, deceit, and misrepresentation in the sales of securities. The Securities Act, which is also referred to as the “truth in securities” law, is part of a legislative effort to govern and oversee the securities industry....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising